XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $10.41 million. The enterprise value is $9.36 million.

Market Cap	10.41M
Enterprise Value	9.36M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025, before market open.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

XTLB has 881.39 million shares outstanding. The number of shares has increased by 29.23% in one year.

Current Share Class	n/a
Shares Outstanding	881.39M
Shares Change (YoY)	+29.23%
Shares Change (QoQ)	+22.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	451.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.09
Forward PS	n/a
PB Ratio	1.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.03.

Current Ratio	0.61
Quick Ratio	0.56
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-77.57

Financial Efficiency

Return on equity (ROE) is -26.83% and return on invested capital (ROIC) is -34.84%.

Return on Equity (ROE)	-26.83%
Return on Assets (ROA)	-24.74%
Return on Invested Capital (ROIC)	-34.84%
Return on Capital Employed (ROCE)	-34.24%
Revenue Per Employee	$45,100
Profits Per Employee	-$102,700
Employee Count	10
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	-130,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.54% in the last 52 weeks. The beta is 0.99, so XTLB's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-46.54%
50-Day Moving Average	1.22
200-Day Moving Average	1.63
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	73,656

Short Selling Information

The latest short interest is 38,865, so 0.58% of the outstanding shares have been sold short.

Short Interest	38,865
Short Previous Month	36,617
Short % of Shares Out	0.58%
Short % of Float	n/a
Short Ratio (days to cover)	4.96

Income Statement

In the last 12 months, XTLB had revenue of $451,000 and -$1.03 million in losses. Loss per share was -$0.00.

Revenue	451,000
Gross Profit	3,000
Operating Income	-2.17M
Pretax Income	n/a
Net Income	-1.03M
EBITDA	-1.97M
EBIT	-2.17M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $1.14 million in cash and $138,000 in debt, giving a net cash position of $1.01 million or $0.00 per share.

Cash & Cash Equivalents	1.14M
Total Debt	138,000
Net Cash	1.01M
Net Cash Per Share	$0.00
Equity (Book Value)	5.44M
Book Value Per Share	0.01
Working Capital	-867,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.62 million and capital expenditures -$54,000, giving a free cash flow of -$1.67 million.

Operating Cash Flow	-1.62M
Capital Expenditures	-54,000
Free Cash Flow	-1.67M
FCF Per Share	-$0.00

Full Cash Flow Statement

Margins

Gross margin is 0.67%, with operating and profit margins of -481.60% and -227.72%.

Gross Margin	0.67%
Operating Margin	-481.60%
Pretax Margin	-256.54%
Profit Margin	-227.72%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.23%
Shareholder Yield	-29.23%
Earnings Yield	-9.86%
FCF Yield	-16.06%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Feb 10, 2017
Split Type	Reverse
Split Ratio	0.2:1

Scores

XTLB has an Altman Z-Score of -23.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.68
Piotroski F-Score	n/a